Pay in 4 interest-free payments of $5.03 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Pancreatic polypeptide infusions reduce food intake in Prader-Willi syndrome
However, always consult the medication guide as well as your healthcare provider to understand potential interactions and safe usage instructions of these two medications
10.1016/j.neuropharm.2011.07.036 40
So far, studies have reported: Phase 2 (48 weeks): up to 24.2% average weight loss Phase 3 TRIUMPH-4 topline (68 weeks): 28.7% average weight loss (press release) What that looks like: If you start at 100 kg : 24.2% 24 kg average loss 28.7% 29 kg average loss Side effects and safety signals (what we know so far) Phase 2 (peer-reviewed) In the phase 2 trial, the most common adverse events were gastrointestinal and dose-related, typically mild to moderate
Common mild side effects: bloating, cramps, gas
US$ 28.87
US$ 20.76
US$ 20.86
US$ 22.19
US$ 21.02
